Related Experiment Video
Updated: Sep 12, 2025

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry
Published on: June 26, 2018
Immune cell subsets in autoimmune polyendocrine syndrome type I
Shahinul Islam1,2, Bergithe E Oftedal1,2, Miriam Gjerdevik3,4
1Department of Medicine, Haukeland University hospital, Bergen, Norway.
Autoimmune Polyendocrine Syndrome Type 1 (APS-I), caused by AIRE gene mutations, shows reduced B cells in Norwegian patients. This study clarifies immune cell differences in APS-I, contrasting with some prior findings on T cells.
Area of Science:
- Immunology
- Genetics
- Endocrinology
Background:
- Autoimmune Polyendocrine Syndrome Type 1 (APS-I) is a rare genetic disorder caused by mutations in the Autoimmune Regulator (AIRE) gene.
- AIRE gene dysfunction is linked to autoimmunity and immune deficiencies, making APS-I a model for studying immune dysregulation.
- Previous studies on blood immune cell subsets in APS-I patients have yielded conflicting results.
Purpose of the Study:
- To investigate high-resolution whole blood immune cell subset distribution in Norwegian APS-I patients.
- To compare immune cell profiles of APS-I patients with age and sex-matched healthy controls.
- To provide a comprehensive summary of existing literature on APS-I immune cell subset findings.
Main Methods:
- Mass cytometry (36-panel assay) was used for detailed immune cell subset analysis in 18 Norwegian APS-I patients and 19 healthy controls.
- A systematic review and meta-analysis of 28 existing studies on APS-I immune cell distribution was performed.
- Statistical comparisons were made between patient and control groups for various immune cell populations.
Main Results:
- Norwegian APS-I patients exhibited significantly reduced numbers of B cells, particularly naïve and transitional B cell compartments.
- Trends indicated reduced frequencies of Natural Killer (NK) cells and altered CD16-expressing cells in APS-I patients.
- Unlike some previous reports, no significant differences in regulatory T cell levels were observed between APS-I patients and controls.
- A meta-analysis of other studies consistently showed lower resting naïve B cells and higher activated memory B cells in APS-I patients.
Conclusions:
- AIRE gene mutations in APS-I are associated with specific alterations in blood immune cell composition, notably reduced B cell numbers.
- The study highlights variability in findings across different research, likely due to factors like medication, ethnicity, and disease complexity.
- Future research should focus on antigen-specific immune responses to better understand APS-I pathogenesis.
Related Concept Videos
What is the Immune System?
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Cell-mediated Immune Responses

